Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.
Calls for the Food and Drug Administration (FDA) to reverse its policy that aims to eliminate patient access to compounded medications containing estriol prescribed by physicians.
Actions
May 7, 2008
Referred to the Subcommittee on Health.
May 6, 2008
Referred to the House Committee on Energy and Commerce.